Immune reconstitution inflammatory syndrome;Syndrome inflammatoire de reconstitution immune

Bulletin de l'Academie Nationale de Medecine

Volumn 195, Issue 3, 2011, Pages 561-575

  Guillaume, Breton ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Antiretroviral therapy; HIV; Immunity

Indexed keywords

EID: 83755219500     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)32064-3     Document Type: Article

References (44)

1. AUTRAN B., CARCELAIN G., LI T.S. et al. - Positive effectof combinated antiretroviral therapy on CD4+T cell homeostasis and function in advanced HIV disease. Science. 1997,277, 112-116. (Pubitemid 27450659)
2. PALELLA F.J., DELANEY K.M., MOORMAN A.C. et al. - Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N. Engl. J. Med., 1998,338, 853-60. (Pubitemid 28135961)
3. FRENCH M.A., PRICE P., STONE S.F. - Immune restoration disease after antiretroviral therapy. AIDS 2004,18, 1615-27. (Pubitemid 39095778)
4. SHELBURNE S.A., HAMILL R.J., RODRIGUEZ-BARRADAS M.C. et al. - Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine 2002,81, 213-227. (Pubitemid 34507208)
5. FRENCH M.A. - Immune reconstitution inflammatory syndrome: a reapparaisal. Clin. Infec. Dis., 2009, 48, 101-107.
6. BRETON G. - Syndrome inflammatoire de reconstitution immune. Med. Sci., 2010,26,281-289.
7. BRETON G. - Syndrome de reconstitution immunitaire chez les patients infectes par le VIH. La lettre de l'infectiologue 2006,3, 116-125.
8. MEINTJES G., LAWN S., SCANIOF. et al. - For the international network for the study of HIV-associated IRIS. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definition for use in resource-limited settings. Lancet Infect. Dis., 2008,8, 516-23. (Pubitemid 352005824)
9. HADDOW L.J., COLEBUNDERS R., MEINTJES G. et al. - Cryptococcal immune reconstitution inflammatory syndrome in HIV-1 infected individuals : proposed clinical case definitions. Lancet Infect. Dis., 2010,10, 791-802.
10. HADDOW L.J., MOOSA M.Y., EASTERBROOK P.J. - Validation of a published case definition for tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS, 2010, 24(1), 103-8.
11. NARITA M., ASHKIN D., HOLLENDER E.S., PITCHENIK A.E. - Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am. J. Respir. Crit. Care Med., 1998,755, 157-61. (Pubitemid 28337174)
12. BRETON G. - Immune reconstitution inflammatory syndrome. In: Schaaf SH and Zumla A, eds. Tuberculosis: a comprehensive clinical reference. Saunders Elsevier. 2009, 689-700.
13. LORTHOLARY O., FONTANET A., NÉMAIN N., MARTIN A., SITBON K., DROMER F. - Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIVassociated cryptococcosis in France. AIDS, 2005,19, 1043-49. (Pubitemid 40961144)
14. BRETON G., ADLE-BIASSETTE H., THERBY A. et al. - Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis. AIDS, 2006,20,119-121. (Pubitemid 41818123)
15. BOURGARIT A., CARCELAIN G., MARTINEZ V. et al. - Explosion of tuberculin-specific T h l - responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS, 2006,20, F1-7.
16. TAN D.B., YONG Y.K., TAN H.Y. et al. - Immunological profiles of immune restoration disease presenting as mycobacterial lympadenitis and cryptococcal meningitis. HIV Med., 2008, 9, 307-316. (Pubitemid 351517278)
17. PRICE P., MORAHAN G., HUANG D. et al. - Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases. AIDS, 2002,16,2043-7. (Pubitemid 35205268)
18. PRICE P., MORAHAN G., HUANG D. et al. - Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases. AIDS, 2002,16,2043-7. (Pubitemid 35205268)
19. ANTONELLI L.R., MAHNKE Y., HODGE J.N. et al. - Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome. Blood, 2010,116, 3818-27.
20. SEDDIKI N., SASSON S.C., SANTANER-NANAN B. et al. - Proliferation of weakly suppressive regulatory CD4 T cells is associated with over-active CD4 T cell response in HIV-positive patients with mycobacterial immune restoration disease. Eur. J. Immunol, 2009,39, 391-403.
21. BOURGARIT A., CARCELAIN G., SAMRI A. et al. - Tuberculosis-associated immune restoration syndrome in HIV-l-infected patients involves tuberculin-specific CD4 Thl cells and KIRnegative gammadelta T cells. J. Immunol, 2009 Sep. 15, 183 (6), 3915-23.
22. VENDRELY A., BIENVENU B., GASNAULT J., THIEBAULT J. B., SALMON D., GRAY F. - Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy. Acta Neuropathol., 2005,109, 449-55. (Pubitemid 40637320)
23. HARTIGAN-O'CONNOR D.J., JACOBSON M. A., TAN Q. X., SINCLAIR E. - for the S t u d i e s of Ocular Comlications of AIDS Research group. Developmentof CMV immune recovery uveitis is associated with T h l 7 cell depletion and poor systemic CMV-specific T cell response. Clin. Infect. Dis., 2011,409-17.
24. BOCHUD P.Y., HAWN T.R., SIDDIQUI M.R. et al. - Toll-Iike receptor 2 polymorphisms are associated with reversai reaction in leprosy. J. Infect. Dis., 2008,197, 253-261. (Pubitemid 351263444)
25. LAWN S.D., MYER L., BEKKER L.G. et al. - Tuberculosis associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS, 2007, 21, 335-341. (Pubitemid 46175045)
26. MANABE Y. C., CAMBELL J. D., SYDNOR E et al. - Immune reconstitution inflammatory syndrome: risk factors and treatment implications. J. Acquir. Immune Defic. Syndr., 2007, 46, 456-462. (Pubitemid 350098697)
27. MURDOCH D. M., VENTER W. D. F., FELDMAN C., VAN RIE A. - Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in south Africa: a prospective study. AIDS, 2008,22, 601-610. (Pubitemid 351640593)
28. SHELBURNE S.A., VISNEGARWALA F., DARCOURT et al. - Incidence and risk factors for immune reconstitution inflammatory syndrome during higly active antiretroviral therapy. AIDS, 2005, 19, 399-406. (Pubitemid 40446186)
29. BRETON G., DUVAL X., ESTELLAT C. et al. - Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy. Clin. Infect. Dis., 2004,39, 1709-12. (Pubitemid 39578550)
30. VALIN N., PACANOWSKI J., DENOEUD L. et al. - Risk factors for unmasking immune reconstitution inflammatory syndrome presentation of tuberculosis following combination antiretroviral therapy initiation in HIV-infected patients. AIDS, 2010,24, 1519-25.
31. GRANT P.M., KOMAROW L., ANDERSEN J. et al. - Risk factor analysis for immune reconstitution inflammatory syndrome in a randomied study of early vs deferred ART during an opportunistic infection. Plos One, 2010, 5e, 11416.
32. LAWN S.D., BEKKER L.G., MILLER R.F. - Immune reconstitution disease associated with mycobacterial infections in HIV-infected indivuduals receiving antiretrovirals. Lancet Infect. Dis., 2005, 5, 361-73. (Pubitemid 40779257)
33. CINQUE P., BOSSOLASCO S., BRAMBILLA A. M. et al. - The effectof HAART - induced immune reconstitution on development and outcome of progressive multifocal encephalopathy : study of 43 cases with review of the litterature. J. Neurovirol, 2003, 9, 73-80. (Pubitemid 36656475)
34. CASTELNUOVO B., MANABE Y. C., KIRRAGA A. et al. - Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort. Clin. Infect. Dis., 2009, 49, 965-72.
35. PEPPERS D. J., MARAIS S., MAARTENS G. et al. - Neurological manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series. Clin. Infect. Dis., 2009, 48, e96-107.
36. PARK W.B., CHOE P.G., Jo J.H. et al. - Immune reconstitution inflammatory syndrome in the first year after HAART: influence on long term outcome. AIDS, 2006,20, 2390-92. (Pubitemid 44789544)
37. KAPLAN J. E., BENSON C., HOMES K. K., BROOKS J. T., MASUR T. T. - Guidelines for prevention and treatment of opportunistics infections in HIV-infected adults and adolescents. MMWR, 2009,58, 1-198.
38. MEINTJES G., WILKINSON R., MORRONI C. et al. - Randomiszed placebo - controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS,24, 2381-90.
39. ZOLOPA A., ANDERSON J., KOMAROW L. et al. - Immediate versus deferred ART in the setting of acute AIDS-related opportunistic infection: final results of a randomized strategy trial, ACTG 5164. Abstract 142. 15lh Conference on Retroviruses and Opportunistic infections. Boston 2008.
40. BLANC FX., SOK T., LAUREILLARD D. et al. - Significant enhancement in survival (with early 52 weeks) vs late (8 weeks) initiation of highly active antiretroviral treatment in severely immuno- suppressed HIV-infected adults with newly diagnosed tubercolisis. Abstract THLBB1. 18th International AIDS. Conference. Vienna 2010.
41. HAVLIR D., IVE P., KENDALL M. et al. - International randomized trial of immediate versus early ART in HIV patients treated for TB : ACTG 5221 STRIDE study. Abstract 38. 18,H conference on retroviruses and opportunistic infections. Boston 2011.
42. ABDOOL-KARIM SS., NAIDOO K., PADAYATCHI N. et al. - Optimal timming of ART during TB therapy: finding of the SAPiT trial. Abstract 39LB. 18th conference on retroviruses and opportunistic infections. Boston 2011.
43. TOROK ME., YEN NTB., CHAU TTH. et al. - Randomised controlled trial of immediate versus deferred antiretroviral therapy in HIV-associated tuberculous meningitis. Abstract H1224.49TH ICAAC. San Francisco 2009.
44. MAKADZANGE AT., NAIDOO K., GROBLER A. et al. - Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub- Saharian Africa. Clin. Infect. Dis., 2010,50, 1532-1538.